Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven? [Yahoo! Finance]
Alimera Sciences, Inc. (ALIM)
Last alimera sciences, inc. earnings: 4/29 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alimerasciences.com/investor-relations
Company Research
Source: Yahoo! Finance
We feel now is a pretty good time to analyse Alimera Sciences, Inc.'s ( NASDAQ:ALIM business as it appears the company may be on the cusp of a considerable accomplishment. Alimera Sciences, Inc., a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. The US$301m market-cap company's loss lessened since it announced a US$21m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$15m, as it approaches breakeven. Many investors are wondering about the rate at which Alimera Sciences will turn a profit, with the big question being “when will the company breakeven?” In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. Alimera Sciences is bordering on breakeven, according to the 4 American Pharmaceuticals analysts. They expect the company to post a final loss in 2024, before turning a profit of US$10m in 2025. Therefore, the company is
Show less
Read more
Impact Snapshot
Event Time:
ALIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALIM alerts
High impacting Alimera Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
ALIM
News
- ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
- Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Alimera Sciences: Deal Closing After All, CVR Still Attractive [Seeking Alpha]Seeking Alpha
- ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of MergerBusiness Wire
- ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences [Yahoo! Finance]Yahoo! Finance
ALIM
Earnings
- 8/6/24 - Miss
ALIM
Sec Filings
- 9/16/24 - Form 4
- 9/16/24 - Form SC
- 9/16/24 - Form S-8
- ALIM's page on the SEC website